We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+20.44%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$476M
AUM Growth
-$38.3M
Cap. Flow
-$67.9M
Cap. Flow %
-14.26%
Top 10 Hldgs %
34.45%
Holding
94
New
29
Increased
20
Reduced
12
Closed
33

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$16.4M
2
DGX icon
Quest Diagnostics
DGX
+$14.4M
3
CI icon
Cigna
CI
+$14.2M
4
UHS icon
Universal Health Services
UHS
+$11.8M
5
ISRG icon
Intuitive Surgical
ISRG
+$10.7M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$16.2M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$14.4M
3
BSX icon
Boston Scientific
BSX
+$13.6M
4
BIIB icon
Biogen
BIIB
+$13.3M
5
CVS icon
CVS Health
CVS
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 93.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOSS icon
76
Gossamer Bio
GOSS
$88.9M
– –
-300,000
Closed -$3.59M
HRTX icon
77
Heron Therapeutics
HRTX
$61.5M
– –
-700,000
Closed -$2.95M
ILMN icon
78
Illumina
ILMN
$29.1B
– –
-30,840
Closed -$5.72M
KURA icon
79
Kura Oncology
KURA
$882M
– –
-500,000
Closed -$6.83M
LFST icon
80
Lifestance Health
LFST
$4.39B
– –
-525,000
Closed -$3.48M
LLY icon
81
Eli Lilly
LLY
$1.08T
– –
-25,000
Closed -$8.08M
MCK icon
82
McKesson
MCK
$105B
– –
-30,000
Closed -$10.2M
MIRM icon
83
Mirum Pharmaceuticals
MIRM
$5.99B
– –
-50,000
Closed -$1.05M
NBIX icon
84
Neurocrine Biosciences
NBIX
$16.5B
– –
-90,000
Closed -$9.56M
PODD icon
85
Insulet
PODD
$10B
– –
-25,000
Closed -$5.74M
PRGO icon
86
Perrigo
PRGO
$1.78B
– –
-320,000
Closed -$11.4M
SIBN icon
87
SI-BONE Inc
SIBN
$843M
– –
-200,000
Closed -$3.49M
THC icon
88
Tenet Healthcare
THC
$20.9B
– –
-130,000
Closed -$6.71M
UNH icon
89
UnitedHealth
UNH
$361B
– –
-15,000
Closed -$7.58M
MRTX
90
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-70,000
Closed -$4.89M
ISEE
91
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-375,000
Closed -$6.73M
CINC
92
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– –
-50,000
Closed -$1.64M
FMTX
93
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-92,000
Closed -$3.31M
HZNP
94
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-30,000
Closed -$1.86M
1 2 3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Integral Health Asset Management held 94 positions worth $476M, down 7.4% from $515M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Integral Health Asset Management withdrew a net $67.9M in Q4 2022, closing 33 positions and reducing 12 holdings. Its most notable exit was Baxter International, an estimated $16.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 96% a quarter earlier.

Against the trend, Integral Health Asset Management opened a new position in Moderna worth $18M.

  • Integral Health Asset Management's largest Q4 2022 buy was Moderna: 100,000 shares worth $18M.
  • Integral Health Asset Management added most to BioMarin Pharmaceuticals in Q4 2022, an estimated $5.91M increase.
  • Integral Health Asset Management's biggest Q4 2022 reduction was Envista, cutting an estimated $11.6M.
  • Integral Health Asset Management fully exited Baxter International in Q4 2022, selling an estimated $16.2M.
  • Integral Health Asset Management's ten largest holdings make up 34% of its $476M portfolio in Q4 2022.
  • Integral Health Asset Management opened 29 new positions and closed 33 in Q4 2022.
  • Integral Health Asset Management's portfolio value fell 7.4% quarter-over-quarter to $476M.

Based on Integral Health Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.